FDA Inspection 1228549 — Hanacos Co., Ltd.

Hanacos Co., Ltd. — FEI 3010166993

The FDA completed an inspection of Hanacos Co., Ltd. on Dec 1, 2023 in Hoengseong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 1, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hoengseong (Korea (the Republic of))

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.